Investigators examined whether intra-abdominal fat is independently associated with hyperuricemia.

The inclusion of electronic pharmacy data in patient or disease registries can facilitate more accurate assessment of quality and effectiveness of care for large groups of patients.

NPSLE is difficult to diagnose and its risk factors remain unclear. A recently published meta-analysis has found several autoantibodies that might facilitate diagnosis and identification of at-risk patients.

Results of an open-label extension of the EMBLEM randomized controlled trial confirm that the novel B-cell modulator epratuzumab is associated with improvements in disease activity and quality of life in patients with moderate to severe systemic lupus erythematosus.

This study highlights the difficulty in diagnosing primary SS, due in part to the absence of gold-standard tests and leading to the use of classification systems instead.

The FDA approved Inflectra (infliximab; Remicade biosimilar) for certain indications including moderately to severely active rheumatoid arthritis in combination with methotrexate, active ankylosing spondylitits, and active psoriatic arthritis.

This study attempted to quantify the effects of peer-led education on quality of life in patients with ankylosing spondylitis.

A new study published suggests that it may be time to produce new algorithms for assessing cardiovascular disease risk in patients with rheumatoid arthritis.

A new study examined the association between varus knee alignment and radiographic progression of knee osteoarthritis.

Researchers in this study sought to describe distinct histological subtypes of temporal artery biopsies.

Foot synovitis may predict patients who are at higher risk of unstable rheumatoid arthritis (RA) remission.

Data from the Persistent Lyme Empiric Antibiotic Study Europe (PLEASE) trial assessed whether longer term use of certain antibiotics resulted in improvements in health-related quality of life after open-label treatment with ceftriaxone.

This study assessed whether TRIM38 autoantibodies could be predictive of disease severity in primary Sjogren syndrome.

A significant association between periodontitis and rheumatoid arthritis is confirmed in a meta-analysis.

The efficacy of baricitinib, an experimental small molecule JAK kinase inhibitor, was assessed in a phase 3 trial of patients with rheumatoid arthritis who had either failed treatment with conventional and synthetic DMARDs, or who were not tolerant of DMARD treatment.

The immunogenicity of the 23-valent pneumococcal vaccine was examined in patients with SLE.

A recent study published in The Journal of Rheumatology found that patients with AS have an increased risk of developing certain depressive disorders following their diagnosis.

A study analyzed the rates of potentially inappropriate prescriptions given to elderly adults at the time of hospital discharge.

This study showed that there are detectable differences in cerebral volume in patients with early SLE, and that control of SLE disease activity was associated with an increase of certain cerebral volumes.

The Health and Public Policy Committee of the American College of Physicians has published a position paper that outlines policies to address the increasing cost of prescription drugs.

Methotrexate (MTX) dosage does not impact the efficacy of certolizumab pegol (CZP) in patients with rheumatoid arthritis receiving combination therapy, suggesting that MTX dose modification is feasible without compromising efficacy.

A populated-based study was conducted to assess if peripheral nerve blocks would improve perioperative outcomes and resource utilization in patients undergoing primary total hip and knee arthroplasty.